Transforming Pharma with End-To-End AI & Robotics | Alex Zhavoronkov at NextMed Health
HTML-код
- Опубликовано: 26 июн 2023
- Alex Zhavoronkov PhD, Founder & CEO of Insilico Medicine at NextMed Health (NextMed.Health) on transforming pharma with end-to-end AI and robotics while solving human aging at the same time.
Insilico Medicine is a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, connects biology, chemistry, and clinical trials analysis using next-generation AI systems. Their mission is to extend healthy productive longevity by transforming drug discovery and development with AI.
More about Alex Zhavoronkov: www.nextmed.health/bio-alexzh...
Join the NextMed Health community, catalyze the future and learn what's now, near and next in health and biomedicine: NextMed.Health/join 
Наука
